
In a target trial emulation using N3C data, adults prescribed metformin within six days of SARS-CoV-2 infection had about half the risk of long COVID or death within six months.
Stephen Klasko, MD, Chief Executive Officer of Thomas Jefferson University Hospitals, discusses the impact of COVID-19 on hospitals around the country.
Segment Description: Stephen Klasko, MD, Chief Executive Officer of Thomas Jefferson University Hospitals, discusses the impact of COVID-19 on hospitals around the country.






